VERSANT HCV Genotype 2.0 Assay (LiPA)

Designed to identify and correctly detect multiple genotypes and subtypes

VERSANT HCV Genotype 2.0 Assay (LiPA)
 
Ihr Kontakt zu uns
VERSANT HCV Genotype 2.0 Assay (LiPA)
VERSANT HCV Genotype 2.0 Assay (LiPA)

The VERSANT® HCV Genotype 2.0 Assay* Line Probe Assay (LiPA) utilizes the trusted reverse-hybridization technology to detect genotypes 1-6 and 15 subtypes including 1a vs.1b and subtypes 6 (c-l) while also taking note of rare patterns that are contained in the updated interpretation chart. This assay is used with the Auto-LiPA 48* and AutoBlot 3000H* automated systems to provide highly accurate identification of HCV genotypes and subtypes for optimal patient therapy.


Share this page:

Verwandte Produkte, Services & Ressourcen

* IVDD, CE marked. For Research Use Only in the United States. Product availability varies from country to country and is subject to local regulatory requirements.